Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03943823 · ClinicalTrials.gov registry record · Phase 4
Postmenopausal Pessary Users: Estrogen Versus Trimosan
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT03943823: Clinical Trial Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
NCT03943823 is a Phase 4 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 4 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03943823, a Phase 4 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of the study is to compare vaginally applied estrogen with the vaginal gel trimosan for their effects on vaginal pH and vaginal symptoms in postmenopausal pessary users.
Primary Outcome
pH is measured on a scale of 0 to 14, with lower values indicating greater acidity and higher values indicating greater alkalinity.
Interventions
- DRUG Estrogen vaginal cream
- DRUG Trimo-San vaginal gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-05-07 |
| Est. Completion | 2021-04-08 |
| Phase | Phase 4 |
Why NCT03943823 stopped before completion
NCT03943823 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Estrogen vaginal cream is the first listed.
NCT03943823 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03943823 about?
NCT03943823 is a clinical study titled "Postmenopausal Pessary Users: Estrogen Versus Trimosan". The purpose of the study is to compare vaginally applied estrogen with the vaginal gel trimosan for their effects on vaginal pH and vaginal symptoms in postmenopausal pessary users.
What is the current status of trial NCT03943823?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2019-05-07. Estimated completion is 2021-04-08.
What interventions are being tested in trial NCT03943823?
The interventions under investigation include: Estrogen vaginal cream (DRUG), Trimo-San vaginal gel (DRUG).
Who is sponsoring clinical trial NCT03943823?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03943823's enrollment target sits among peer trials
4 1994th of 2000 higher than 6 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI